Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Veoneer appoints Chief Technology Officer, refines organization

Stockholm, Sweden, October 24, 2018: Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), the world’s largest pure-play company focused on Advanced Driving Assistance Systems (ADAS) and Automated Driving (AD), has appointed Mr. Nishant Batra to the new position as Executive Vice President (EVP) and Chief Technology Officer (CTO) and is refining its management and reporting structure within the Electronics Segment.Mr. Batra has been appointed EVP and CTO. Most recently, he was head of Network Products within Ericsson.  Batra has held several key positions in the US, Sweden, and India since joining

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock Investment Management (UK) Limited’s holding in Wärtsilä

Wärtsilä Corporation Stock exchange release 24 October 2018 at 9.30 am EESTBlackRock, Inc. has informed Wärtsilä Corporation that the number of Wärtsilä’s shares and voting rights held by BlackRock Investment Management (UK) Limited crossed above the 5% disclosure limit on 22 October 2018. Following the transaction BlackRock Investment Management (UK) Limited owns 5.005% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.029%. The total number of shares held by BlackRock, Inc. and its funds subject to the notification is 8.42% of

Reminder: Invitation to the presentation of Orkla's results for the third quarter of 2018 on Thursday, 25 October 2018

Orkla will publish its third quarter 2018 results on Thursday, 25 October at 07:00 CEST. The quarterly report and presentation material will be made available at this time at www.orkla.com. Telephone conference call at 08:00 CEST:  President and CEO Peter A. Ruzicka and CFO Jens Staff will present the results in a telephone conference call at 08:00 CEST. The presentation and subsequent Q&A session will be held in English. To participate in the conference call, the following dial-in numbers may be used: Norway: +47 23500243, PIN: 49540027# Denmark: +45 35445577, PIN: 49540027#

Hexagon Composites ASA: Invitation to presentation of third quarter 2018 results

Hexagon Composites ASA will report its third quarter 2018 results on 31 October in Oslo. Shareholders, analysts and others with an interest in Hexagon Composites ASA are welcome to the presentation of the Company's results. Quarterly earnings release:Time: Wednesday 31 October 2018 at 07:00 CETInterim report and presentation material will be released and made available on www.hexagon.no and www.newsweb.no Results presentation:Time: Wednesday 31 October 2018 at 08:30 CETPlace: Felix Conference Center - Aker Brygge, OsloLanguage: English The company will be represented

#18-1955 Recalculation of reference value for certain instruments with Tesla Motors Inc. as underlying security

The reference value for certain certificates have been recalculated in accordance with the instruments final terms. This applies to the following instruments: Symbol: BEAR TSLA X10 V3 Symbol: BEAR TESLA X10 VON3 Symbol: BEAR TESLA X10 VON2 Symbol: BEAR TESLA X8 VON2 Symbol: BEAR TESLA X8 VON Symbol: BEAR TESLA X10 C Symbol: BEAR TESLA X8 CThe instruments will be traded under observation for the duration of this trading day. For more information concerning the recalculation, please contact the issuer of the affected instrument. For further information concerning

ÅF appoints new member to Group Management

ÅF has appointed Peter Plug as new EVP & Head of the Energy Division and member of Group Management. Peter has over 13 years of experience within the energy sector and joined ÅF in 2013.“I am very pleased that Peter has accepted the role as Executive Vice President for the Energy Division. He has a solid experience from the European energy sector, and has shown a strong leadership in his former roles within ÅF. Together with his management team he will now take on the job of implementing the ÅF Future Strategy and repositioning the division according to the ongoing energy transformation,”

Asarina Pharma over-allotment option fully exercised as stabilization period of share offering ends

Stockholm - October 24, 2018: Erik Penser Bank (“EPB”) has been the stabilization manager for Asarina Pharma AB (publ) in connection with its recent offering of 6,800,000 new shares ("the Offer"), and the listing of the Company’s shares on Nasdaq First North. EPB hereby announces the stabilization period of thirty calendar days following the listing of the Company's shares ended 23 October, with no stabilization transactions having been carried out.In its capacity as stabilization manager, EPB had the authority to carry out transactions aimed at supporting the price of the Asarina share at

Interim report January-September 2018: Positive trend of high volumes continues and earnings improve

Third quarter · Order intake rose by 25% to 372 MSEK (297). · Net sales increased by 17% to 338 MSEK (289). · EBIT was 17.7 MSEK (5.6). · Profit after tax increased to 11.0 MSEK (-2.2). · Earnings per share increased to 0.38 SEK (-0.09). Nine months · Order intake rose by 24% to 1,141 MSEK (922). · Net sales increased by 17% to 1,036 MSEK (883). · EBIT was 53.7 MSEK (14.6). · Profit/loss after tax increased to 31.1 MSEK (-5.2). · Earnings per share increased to 1.08 SEK (-0.22). COMMENTS FROM CEO PER SAMUELSSON ”The progress of Beijer Electronics

BioGaia AB - Interim management statement 1 January – 30 September 2018

Comments from the Managing Director: “The third quarter of 2018 was yet another strong quarter with growth of 18% (10% after foreign exchange effects) compared to the corresponding period last year. The increase was driven by sales of BioGaia Protectis drops as well as by favorable growth for BioGaia Prodentis lozenges. Geographically, growth was strong across all three regions, EMEA, Asia Pacific and the Americas. It is worth noting that sales increased significantly in the USA and the rollout of BioGaia Gastrus tablets continues with good growth. Sales for the past 12-month period

Nitro Games signs Agreement with Huawei

Nitro Games has signed a Sponsorship and Partnership Agreement with Aspiegel Limited, a subsidiary of Huawei, related to Nitro Games’ new game Heroes of Warland and the reality show Heroes & Superstars.This Agreement is about visibility for Huawei through Sponsorship in connection with Heroes & Superstars reality show, produced by Gamingzone Entertainment, and Partnership opportunities with Heroes of Warland, developed by Nitro Games. The Sponsorship part of the Agreement includes a minor upfront payment to Nitro Games. The purpose of the Partnership Agreement is in mutually beneficial

LKAB present Interim Report for the third quarter on October 26th

The Interim Report for the third quarter 2018 will be published at 8.00 a.m. Friday 26 October on the LKAB website: www.lkab.com/financial-reportsThe report is sent as a press release and will be published at www.lkab.com Press ConferenceJan Moström, LKAB's President and CEO, Pierre Heeroma, Senior Vice President Exploration, Strategy and Business Development and Michael Palo, Senior Vice President Northern Division, will be available at a press conference about the Interim Report and other current issues at LKAB Jägarskolan in Kiruna, Friday 26 October at 12.00 local time. To

Strong result for third quarter

Södra reported a sustained strong operating profit of SEK 1,277 million (437) for the third quarter of 2018. All business areas reported strong results and market conditions for forest products remain favourable for the immediate future.Net sales for the third quarter rose 22 percent to SEK 5,826 million (4,763) compared with the year-earlier period, and the operating margin improved to 22 percent (9). Net sales amounted to SEK 18,168 million (15,105) for the first nine months of the year. Operating profit totalled SEK 3,533 million (1,388) – a very strong nine-month figure. Return on

Orexo appoints Joseph DeFeo as new CFO

Uppsala, Sweden – October 24, 2018 - Orexo AB announces today that the company appoints Joseph DeFeo as the company’s new Chief Financial Officer (CFO) from November 1, 2018. Joseph DeFeo will succeed Henrik Juuel who will join the Danish company Bavarian Nordic A/S as their new CFO. Joseph DeFeo is located in the US and has previously been the Head of Finance and Head of Operations in Orexo’s subsidiary in the US. Prior to joining Orexo Joseph DeFeo has worked in several senior finance positions among others establishing of US operations for a large Italian pharmaceutical company, Head

Interim report January-September 2018

PROFIT IMPACTED BY PROJECT IMPAIRMENTSJuly–September 2018 · Income amounted to SEK 1,359 million (1,271), an increase of 7 percent · The operating loss amounted to SEK 40 million (profit 67) · The loss for the period amounted to SEK 55 million (profit 51) · Earnings per share after dilution amounted to a negative SEK 2.42 (2.18) · Cash flow from operating activities amounted to a negative SEK 9 million (84) · Order bookings amounted to SEK 1,236 million (691) · During the quarter, Construction was impacted negatively by project impairments of SEK 70 million January-

ROTTNEROS INTERIM REPORT JANUARY – SEPTEMBER 2018

RECORD PROFIT FOR THE THIRD QUARTER · Net turnover for the third quarter of 2018 rose by 27% to SEK 601m (472). · EBIT for the third quarter of 2018 increased by 152% to SEK 111m (44) and represents a record for a single quarter in the Group’s current structure, despite the cost of annual maintenance shutdown in Rottneros Mill during the quarter. · Profit after financial items for the third quarter surged to SEK 106m (41) and for the nine months to SEK 269m (159). Earnings per share for the third quarter rose to SEK 0.54 (0.21) and for the nine months to SEK 1.39 (0.81). ·

Interim Report January-September 2018

Improved profit and continued good growth”We are strengthening profit and the pace of growth is persistently good, with 6 percent organic growth and 10 acquisitions so far this year. At the same time, we’re proud that ÅF is the best in the industry when Swedish engineers vote for the most attractive employer,” said Jonas Gustavsson, President and CEO. Third quarter 2018 · • Net sales amounted to SEK 2,995 million (2,662) · • EBITA excl items affecting comparability, was SEK 220 million (184) · • EBITA margin, excl items affecting comparability, was 7.4 percent (6.9) · •

Sahar Kupersmidt appointed SVP & Head of Nordic DTH TV

· Sahar Kupersmidt takes on Nordic responsibility for NENT Group’s Viasat satellite operator business · Mahmoud Mustapha appointed VP & Head of Pay TV Sweden Nordic Entertainment Group (NENT Group) has appointed Sahar Kupersmidt as SVP & Head of Nordic DTH TV. Sahar will lead the region wide development of NENT Group’s Viasat satellite operator business, which offers pay TV services to customers in Denmark, Finland, Norway and Sweden. In her new role, Sahar will hold commercial, strategic and business development responsibility for Viasat’s satellite operator activities in the

Interim report January-September 2018

Strong growth and increasing profitability"Mycronic delivered a strong third quarter, while we see stable market development within the segments where we operate. We are demonstrating robust growth, we are improving our margins, and we have a healthy order intake with a number of significant orders added during the quarter. Net sales for Assembly Solutions grew 104 percent, with a 45 percent increase in orders. The consolidated order intake as a whole was affected by a challenging comparison because of a record order in Pattern Generators in mid-September last year," says Lena Olving,

Hansa Medical Receives Positive Opinion for Orphan Drug Designation in the EU for Imlifidase for Anti-GBM Disease

Lund, Sweden, October 24, 2018- Hansa Medical AB (NASDAQ Stockholm:HMED), the leading biopharma company focusing on inhibition of immunoglobulin G (IgG)-mediated immunopathologies, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on Orphan Drug Designation for imlifidase for the treatment of anti-glomerular basement membrane (anti-GBM) antibody disease. A positive opinion by the COMP precedes official designation by the European Commission."This positive opinion on Orphan Drug Designation for

Interim report January – September 2018

Low organic growth July – September 2018  · Revenue increased to MEUR 70.1 (69.2) · Organic growth was 1.1% · The gross margin was 43.0% (42.4) · Adjusted EBITA amounted to MEUR 6.1 (6.3), corresponding to a margin of 8.6% (9.1) · EBIT amounted to MEUR 4.6 (0.3), corresponding to a margin of 6.6% (0.5) · Adjusted operating cash flow amounted to MEUR 1.0 (2.8) · Vehicle Accessibility was negatively impacted by delayed deliveries due to new regulations. The negative effects on revenue and EBITA are estimated at c. MEUR -0.5 and c. MEUR -0.2 respectively · Staffan

Kesko interim report for the period 1 Jan. - 30 Sept. 2018: improved comparable operating profit and all-time-best quarterly performance in Q3

FINANCIAL PERFORMANCE IN BRIEF, CONTINUING OPERATIONS: · The Group's net sales in January-September totalled €7,728 million (€7,917 million), an increase of 3.6% in comparable terms · Comparable operating profit was €241.7 million (€215.8 million) · Operating profit was €228.2 million (€267.8 million) · Cash flow from operating activities was €309.6 million (€181.2 million). · Comparable return on capital employed was 13.8% (12.4%) (rolling 12 months) · Comparable profit before tax was €237.7 million (€218.7 million) · Comparable earnings per share were €1.77 (€1.64)

Fortum's January-September 2018 Interim Report: Historically low hydro volumes impacted the results, partly offset by higher power prices

FORTUM CORPORATION JANUARY-SEPTEMBER 2018 INTERIM REPORT 24 OCTOBER 2018 AT 9:00 EEST This release is a summary of Fortum’s January-September 2018 Interim Report. The complete report is attached to this release as a pdf-file. It is also available on the company's website at www.fortum.com/investors. July-September 2018 · Comparable EBITDA was EUR 230 (210) million, +10%, including EUR 26 million profit from selling a 54% share of Fortum's Indian solar power plants · Comparable operating profit was EUR 96 (94) million, +2%, including EUR 26 million Indian solar profit Cash flow

There are no items matching the current filter
There are no more items matching the current filter
Back to top